This is particularly relevant for patients managing fibromyalgia, complex regional pain syndrome, and post-surgical chronic pain
Why This Matters in MCAS In MCAS, chronic mast-cell activation in the gut, brain, and connective tissues can damage the enteric and autonomic nervous systems, contributing to symptoms such as nausea, motility issues, dysautonomia, and neuroinflammatory fatigue
Recent studies highlight additional health benefits, including their influence on inflammation, support for brain health, improvement in cardiovascular function, and contribution to slowing cellular aging
The FDA approved Liraglutide, the first generic of a once-daily GLP-1 injection, in December 2024